ELIZABETH PLIMACK (177)

PARTICIPATION IN THE CONFERENCE AGENDA

AS A MEMBER OF THE PROGRAM

Date	Time	Session Title	Presentation Time	Topic	Role
14/10/2021	19:20 to 21:00	GU-Review Câncer Renal Metastático Metastatic Renal Cell Carcinoma	20:20 to 20:30	Point- counterpoint session: First line treatment of favorable risk metastatic RCC: I recommend TKI plus ICI	Speaker
14/10/2021	19:20 to 21:00	GU-Review Câncer Renal Metastático Metastatic Renal Cell Carcinoma	20:30 to 21:00	Discussion and questions	Discussant